Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01472471 · ClinicalTrials.gov registry record

Urinary 8-isoprostane is Elevated in Acute Childhood Asthma

A clinical trial of Oxidative Stress and Childhood Asthma, sponsored by Stony Brook University.

Completed
Registry status
52
Enrollment target
1
Study location

NCT01472471 is a study of Oxidative Stress and Childhood Asthma that has completed, run by Stony Brook University. The registered enrollment target is 52 participants, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01472471, a study of Oxidative Stress and Childhood Asthma, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
52 participants
Enrollment target
1
Study location

Study Summary

Oxidative stress is seen in children with asthma, but is hard to measure. The investigators exploring the utility of using a commercially available assay to measure oxidative stress in the urine in asthmatics. Additionally, the investigators will attempt to prove that oxidative stress is higher in children with acute asthma compared to those with stable asthma and that this stress is also higher in children with more severe clinical asthma exacerbations compared to less severe ones.

Study Locations (1)

New York

  • Long Island Children's Hospital at Stony Brook - Stony Brook

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2010-11
Est. Completion 2012-02

Sponsor

Stony Brook University

127 total trials

What the Registry Record Tells You About NCT01472471

The ClinicalTrials.gov registry entry for NCT01472471 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 36 other Oxidative Stress trials with a reported enrollment target (39% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 0 interventions.

NCT01472471 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01472471 about?

NCT01472471 is a clinical study titled "Urinary 8-isoprostane is Elevated in Acute Childhood Asthma". Oxidative stress is seen in children with asthma, but is hard to measure. The investigators exploring the utility of using a commercially available assay to measure oxidative stress in the urine in asthmatics. Additionally, the investigators will attempt to prove that oxidative stress is higher in c...

What is the current status of trial NCT01472471?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2010-11. Estimated completion is 2012-02.

What conditions does trial NCT01472471 study?

This clinical trial studies the following conditions: Oxidative Stress, Childhood Asthma.

Who is sponsoring clinical trial NCT01472471?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01472471 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxidative Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.